P8 patient prioritisation of items for the new Patient-Reported Impact of Dermatological Diseases (PRIDD) measure: A delphi study

The Global Research on the Impact of Dermatological Diseases (GRIDD) team is developing the new Patient-Reported Impact of Dermatological Diseases (PRIDD) measure, a patient-reported outcome measure of the impact of dermatological conditions on the patient’s life. We developed a conceptual framework through a qualitative interview study with 68 patients globally to derive impact items. This study aimed to seek consensus from patients on which items to prioritise for inclusion in PRIDD